Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The current gold standard for treatment of chronic hepatitis C (CHC) patients is with
pegylated interferon plus ribavirin. Drug administration accuracy and ease of use will
definitely determine treatment effectiveness. This is the idea behind the development and
usage of the PegPen. The goal of this study is to determine the satisfaction grade with this
novel device.